SALT LAKE CITY (CN) - 3M Pharmaceuticals failed to warn that it had no idea whether its "Aldara Cream," imiquimod, used to treat superficial basal cell carcinoma, is appropriate for people with suppressed immune systems, and it gave a man a pulmonary embolism and other ruinous health problems, he claims in Salt Lake County Court. See complaint.
Categories / Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.
Additional Reads
-
-
Texans head to the polls for high-stakes US Senate primary February 17, 2026